Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
BIOLOGICAL

Pneumovax (PPSV23)

Injection

BIOLOGICAL

Prevnar (PCV7)

Injection

Trial Locations (18)

15213

University of Pittsburgh Emphysema Research Center, Pittsburgh

19140

Temple University Lung Center, Philadelphia

21201

University of Maryland Hospital, Baltimore

35249

University of Alabama at Birmingham, Birmingham

48105

Veteran's Administration Medical Center, Ann Arbor

55417

Veteran's Administration Medical Center, Minneapolis

55440

HealthPartners Research Foundation, Minneapolis

55905

Mayo Clinic, Rochester

80220

Veteran's Administration Medical Center, Denver

90502

LA BioMed at Harbor, University of California, Los Angeles

94143

University of California San Francisco-Airway Clinical Research Center, San Francisco

35294-0006

Veteran's Administration Medical Center, Birmingham

80204-4507

Denver Health Medical Center, Denver

National Jewish Medical and Research Center, Denver

02115

Fallon Clinic, Boston

02132

Brigham and Women's Hospital, Boston

Veteran's Administration Medical Center, Boston

48109-0360

University of Michigan Medical Center, Ann Arbor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Minnesota

OTHER

NCT00457977 - Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter